rolipram has been researched along with Cognition Disorders in 11 studies
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with rolipram increased expression of CREB and pCREB, reduced the inflammatory reaction (decreased TNF-α levels and increased IL-10 levels), and prevented cognitive impairment in these diabetic animals." | 1.42 | Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats. ( He, T; Li, W; Miao, Y; Wang, B; Zhong, Y; Zhu, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Titus, DJ | 1 |
| Sakurai, A | 1 |
| Kang, Y | 1 |
| Furones, C | 1 |
| Jergova, S | 1 |
| Santos, R | 1 |
| Sick, TJ | 1 |
| Atkins, CM | 1 |
| Miao, Y | 2 |
| He, T | 2 |
| Zhu, Y | 2 |
| Li, W | 2 |
| Wang, B | 1 |
| Zhong, Y | 2 |
| Jabaris, SS | 1 |
| Sumathy, H | 1 |
| Girish, R | 1 |
| Narayanan, S | 1 |
| Sugumar, M | 1 |
| Saravana Babu, C | 1 |
| Thanikachalam, S | 1 |
| Thanikachalam, M | 1 |
| Yan, H | 1 |
| Myeku, N | 1 |
| Clelland, CL | 1 |
| Emrani, S | 1 |
| Kukushkin, NV | 1 |
| Yu, WH | 1 |
| Goldberg, AL | 1 |
| Duff, KE | 1 |
| Kelly, MP | 1 |
| Stein, JM | 1 |
| Vecsey, CG | 1 |
| Favilla, C | 1 |
| Yang, X | 1 |
| Bizily, SF | 1 |
| Esposito, MF | 1 |
| Wand, G | 1 |
| Kanes, SJ | 1 |
| Abel, T | 1 |
| Wang, C | 1 |
| Yang, XM | 1 |
| Zhuo, YY | 1 |
| Zhou, H | 2 |
| Lin, HB | 1 |
| Cheng, YF | 1 |
| Xu, JP | 1 |
| Zhang, HT | 1 |
| Giralt, A | 1 |
| Saavedra, A | 1 |
| Carretón, O | 1 |
| Xifró, X | 1 |
| Alberch, J | 1 |
| Pérez-Navarro, E | 1 |
| Ramos, BP | 1 |
| Birnbaum, SG | 1 |
| Lindenmayer, I | 1 |
| Newton, SS | 1 |
| Duman, RS | 1 |
| Arnsten, AF | 1 |
| Comery, TA | 1 |
| Martone, RL | 1 |
| Aschmies, S | 1 |
| Atchison, KP | 1 |
| Diamantidis, G | 1 |
| Gong, X | 1 |
| Kreft, AF | 1 |
| Pangalos, MN | 1 |
| Sonnenberg-Reines, J | 1 |
| Jacobsen, JS | 1 |
| Marquis, KL | 1 |
| Costa, DA | 1 |
| Cracchiolo, JR | 1 |
| Bachstetter, AD | 1 |
| Hughes, TF | 1 |
| Bales, KR | 1 |
| Paul, SM | 1 |
| Mervis, RF | 1 |
| Arendash, GW | 1 |
| Potter, H | 1 |
11 other studies available for rolipram and Cognition Disorders
| Article | Year |
|---|---|
Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injury.
Topics: Animals; Brain Injuries; Chronic Disease; Cognition Disorders; Conditioning, Psychological; Cyclic A | 2013 |
Activation of Hippocampal CREB by Rolipram Partially Recovers Balance Between TNF-α and IL-10 Levels and Improves Cognitive Deficits in Diabetic Rats.
Topics: Animals; Cognition Disorders; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Experi | 2015 |
Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
Topics: Adrenergic alpha-2 Receptor Agonists; Aminopyridines; Animals; Antihypertensive Agents; Benzamides; | 2015 |
Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels.
Topics: Animals; Apoptosis Regulatory Proteins; Brain-Derived Neurotrophic Factor; Cognition; Cognition Diso | 2016 |
Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.
Topics: Animals; Behavior, Animal; Brain; Cognition; Cognition Disorders; Cyclic AMP; Cyclic AMP-Dependent P | 2016 |
Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.
Topics: Acetylcysteine; Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Newborn; | 2009 |
The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Avoidance Learning; bcl-2-Associated X Protein; Cognition | 2012 |
Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
Topics: Animals; Calcineurin; Cognition Disorders; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide P | 2011 |
Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aging; Animals; Cognition Disorders; Cyclic AMP; Cyclic AMP Res | 2003 |
Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-P | 2005 |
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; | 2007 |